R. Kirk Huntsman

CEO

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

Affiliation history

Recorded current and former roles; source labels appear when available.

Recorded roles and earnings-call appearances connecting this person to public companies.

VVOS

Current role

CEO

1 call Latest call 2026-04-15

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2024	Vivos Therapeutics, Inc. (VVOS)	Chief Executive Officer	$408,700	—	—	$801,578	$77,695	$18,933	$1,306,906
2023	Vivos Therapeutics, Inc. (VVOS)	Chief Executive Officer	$463,393	—	—	—	—	$18,765	$657,701
2022	Vivos Therapeutics, Inc. (VVOS)	Chief Executive Officer	$384,853	—	—	$483,802	$50,647	$18,548	$937,850
2021	Vivos Therapeutics, Inc. (VVOS)	Chief Executive Officer	$344,229	—	—	$570,300	$144,318	$18,302	$1,077,149
2020	Vivos Therapeutics, Inc. (VVOS)	Chief Executive Officer	$251,784	—	—	—	$177,847	$25,705	$455,336

Earnings-call appearances and filed executive appointments or departures, newest first.